Loomis Sayles & CO L P Acadia Pharmaceuticals Inc Transaction History

Loomis Sayles & CO L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $7.18 Million - $15.8 Million	-287,133 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $11.8 Million - $16.3 Million	287,133 New	287,133 $15.4 Million
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $7.21 Million - $11.3 Million	-198,031 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $7.77 Million - $10.4 Million	198,031 New	198,031 $9.6 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.